Skip to main content

Table 2 Patient Characteristics.

From: Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer

Characteristics n
Age (years)  
   Median 64
   Range 49–77
Gender  
   Male 9
   Female 9
ECOG performance status  
   0 5
   1 12
   2 1
   Not Reported 3
Tumor Type  
   NSCLC 15
   SCLC 3
Previous Chemotherapy Regimens  
   1 5
   2 2
   3 5
   ≥4 6
Prior Radiotherapy 6
\